These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 29432346)

  • 21. 68Ga-DOTATATE Uptake in Pancreatic Metastasis of Renal Cell Carcinoma Mimicking Pancreatic Neuroendocrine Tumor.
    Soydal C; Nak D; Araz M; Demirkazik A; Kucuk NO
    Clin Nucl Med; 2019 Oct; 44(10):795-796. PubMed ID: 31306201
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Influence of PET/CT 68Ga somatostatin receptor imaging on proceeding with patients, who were previously diagnosed with 99mTc-EDDA/HYNIC-TOC SPECT.
    Madrzak D; Mikołajczak R; Kamiński G
    Nucl Med Rev Cent East Eur; 2016; 19(2):88-92. PubMed ID: 27479886
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Hepatocellular Carcinoma Mimicking Neuroendocrine Tumor Metastasis on 68Ga-DOTATATE PET/CT.
    Ulaner GA; Bodei L
    Clin Nucl Med; 2019 Apr; 44(4):330-331. PubMed ID: 30688738
    [TBL] [Abstract][Full Text] [Related]  

  • 24. 68Ga-DOTATOC versus 68Ga-DOTATATE PET/CT in functional imaging of neuroendocrine tumors.
    Poeppel TD; Binse I; Petersenn S; Lahner H; Schott M; Antoch G; Brandau W; Bockisch A; Boy C
    J Nucl Med; 2011 Dec; 52(12):1864-70. PubMed ID: 22072704
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Neuroendocrine Tumor Diagnosis and Management:
    Sanli Y; Garg I; Kandathil A; Kendi T; Zanetti MJB; Kuyumcu S; Subramaniam RM
    AJR Am J Roentgenol; 2018 Aug; 211(2):267-277. PubMed ID: 29975116
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The Clinical Impact of [
    Wannachalee T; Turcu AF; Bancos I; Habra MA; Avram AM; Chuang HH; Waguespack SG; Auchus RJ
    Clin Endocrinol (Oxf); 2019 Aug; 91(2):288-294. PubMed ID: 31066920
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Comparison of the Impact of 68Ga-DOTATATE and 18F-FDG PET/CT on Clinical Management in Patients with Neuroendocrine Tumors.
    Panagiotidis E; Alshammari A; Michopoulou S; Skoura E; Naik K; Maragkoudakis E; Mohmaduvesh M; Al-Harbi M; Belda M; Caplin ME; Toumpanakis C; Bomanji J
    J Nucl Med; 2017 Jan; 58(1):91-96. PubMed ID: 27516446
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The Impact of Somatostatin Receptor-Directed PET/CT on the Management of Patients with Neuroendocrine Tumor: A Systematic Review and Meta-Analysis.
    Barrio M; Czernin J; Fanti S; Ambrosini V; Binse I; Du L; Eiber M; Herrmann K; Fendler WP
    J Nucl Med; 2017 May; 58(5):756-761. PubMed ID: 28082438
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The utility of
    Tirosh A; Kebebew E
    Future Oncol; 2018 Jan; 14(2):111-122. PubMed ID: 29072093
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Impact of 68Ga-DOTATATE PET/CT on the management of neuroendocrine tumors: the referring physician's perspective.
    Herrmann K; Czernin J; Wolin EM; Gupta P; Barrio M; Gutierrez A; Schiepers C; Mosessian S; Phelps ME; Allen-Auerbach MS
    J Nucl Med; 2015 Jan; 56(1):70-5. PubMed ID: 25500825
    [TBL] [Abstract][Full Text] [Related]  

  • 31. 68Ga-DOTATATE: Significance of Uptake in the Tail of the Pancreas in Patients Without Lesions.
    Delbeke D; Newman G; Deppen S; Shah C; Ndolo J; Shi C; Bailey CE; Jessop AC; Sandler MP
    Clin Nucl Med; 2019 Nov; 44(11):851-854. PubMed ID: 31524686
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Most of the Intended Management Changes After
    Calais J; Czernin J; Eiber M; Fendler WP; Gartmann J; Heaney AP; Hendifar AE; Pisegna JR; Hecht JR; Wolin EM; Slavik R; Gupta P; Quon A; Schiepers C; Allen-Auerbach MS; Herrmann K
    J Nucl Med; 2017 Nov; 58(11):1793-1796. PubMed ID: 28473600
    [TBL] [Abstract][Full Text] [Related]  

  • 33. High management impact of Ga-68 DOTATATE (GaTate) PET/CT for imaging neuroendocrine and other somatostatin expressing tumours.
    Hofman MS; Kong G; Neels OC; Eu P; Hong E; Hicks RJ
    J Med Imaging Radiat Oncol; 2012 Feb; 56(1):40-7. PubMed ID: 22339744
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Occurrence of the Redifferentiation-Akin Phenomenon on
    Sharma P; Basu S
    J Nucl Med Technol; 2020 Sep; 48(3):290-291. PubMed ID: 32111657
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Direct comparison of (68)Ga-DOTA-TOC and (18)F-FDG PET/CT in the follow-up of patients with neuroendocrine tumour treated with the first full peptide receptor radionuclide therapy cycle.
    Nilica B; Waitz D; Stevanovic V; Uprimny C; Kendler D; Buxbaum S; Warwitz B; Gerardo L; Henninger B; Virgolini I; Rodrigues M
    Eur J Nucl Med Mol Imaging; 2016 Aug; 43(9):1585-92. PubMed ID: 26922350
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Overexpression of somatostatin receptor type 2 in neuroendocrine tumors for improved Ga68-DOTATATE imaging and treatment.
    Guenter R; Aweda T; Carmona Matos DM; Jang S; Whitt J; Cheng YQ; Liu XM; Chen H; Lapi SE; Jaskula-Sztul R
    Surgery; 2020 Jan; 167(1):189-196. PubMed ID: 31629542
    [TBL] [Abstract][Full Text] [Related]  

  • 37.
    Tierney JF; Kosche C; Schadde E; Ali A; Virmani S; Pappas SG; Poirier J; Keutgen XM
    Surgery; 2019 Jan; 165(1):178-185. PubMed ID: 30415869
    [TBL] [Abstract][Full Text] [Related]  

  • 38. 68Ga-DOTATATE PET/CT for the early prediction of response to somatostatin receptor-mediated radionuclide therapy in patients with well-differentiated neuroendocrine tumors.
    Haug AR; Auernhammer CJ; Wängler B; Schmidt GP; Uebleis C; Göke B; Cumming P; Bartenstein P; Tiling R; Hacker M
    J Nucl Med; 2010 Sep; 51(9):1349-56. PubMed ID: 20720050
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Rare Occurrence of Hypergastrinemia Due to Thoracic Neuroendocrine Tumor: Detection and Characterization by 68Ga-DOTATATE PET/CT.
    Sampathirao N; Basu S
    J Nucl Med Technol; 2016 Sep; 44(3):203-4. PubMed ID: 26848167
    [TBL] [Abstract][Full Text] [Related]  

  • 40. 68Ga-DOTATATE PET/CT in Primary Hepatic Neuroendocrine Tumor.
    Gorla AK; Basher RK; Kaman L; Bal A; Bhattacharya A; Mittal BR
    Clin Nucl Med; 2017 Feb; 42(2):118-120. PubMed ID: 28005645
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.